You need
{credits} Credits
to reach your goal.
More about
Pik3ca-Mutated Advanced Breast Cancer
News
October 31, 2024
3 min read
Save
Inavolisib regimen extends PFS in PIK3CA-mutated advanced breast cancer
The addition of inavolisib to palbociclib and fulvestrant more than doubled PFS for certain patients with advanced breast cancer, according to results of a randomized phase 3 trial.
